Triptolide targets <i>JUN</i> to reverse cisplatin resistance of ovarian cancer: insights from single-cell transcriptome analysis and machine learning validation.

Front Pharmacol · 2026 · PMC13391933 · PMID 42494522

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

qRT-PCR results ( Figure 9C ) showed a highly significant decrease of JUN in the si-JUN group compared to the si-NC group.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Triptolide targets &lt;i&gt;JUN&lt;/i&gt; to reverse cisplatin resistance of ovarian cancer: insights from single-cell transcriptome analysis and machine learning validation.

The sentences

Triptolide targets <i>JUN</i> to reverse cisplatin resistance of ovarian cancer: insights from single-cell transcriptome analysis and machine learning validation.